z-logo
open-access-imgOpen Access
B cell responses to the 2011/12-influenza vaccine in the aged
Author(s) -
Raj K. Kurupati,
Senthil Kannan,
■ Xiang,
Zhi Quan Xiang,
Susan A. Doyle,
Sarah J. Ratcliffe,
Kenneth E. Schmader,
Hildegund C.J. Ertl
Publication year - 2013
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.100541
Subject(s) - elispot , peripheral blood mononuclear cell , flow cytometry , virology , cd19 , antibody , vaccination , immunology , cd38 , influenza vaccine , virus , biology , immunoglobulin d , medicine , b cell , immune system , t cell , in vitro , cd34 , biochemistry , genetics , stem cell
Antibody and B cell responses to influenza A viruses were measured over a period of 2 months in 30 aged and 15 middle-aged individuals following vaccination with the 2011/12 trivalent inactivated influenza vaccine by micro-neutralization assays, ELISAs, ELISpot assays and cell surface staining with lineage-defining antibodies followed by multicolor flow cytometry. Both cohorts developed comparable antibody responses to the H3N2 virus of the vaccine while responses to the H1N1 virus were compromised in the aged. ELISpot assays of peripheral blood mononuclear cells (PBMCs) gave comparable results for the two cohorts. Analysis by flow cytometry upon staining of CD19+IgD-CD20- PBMCs with antibodies to CD27 and CD38 showed markedly reduced increases of such cells following vaccination in the aged. Additional analysis of cells from a subset of 10 younger and 10 aged individuals indicated that in the aged a portion of IgG producing cells lose expression of CD27 and reduce expression of CD38.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom